Market By Application, Component, And Country | Forecast 2021-2028
The Asia-Pacific precision medicine market is deemed to display growth at 10.53% of CAGR during the examined years 2021-2028.
The countries assessed in this market include:
• India
• China
• Japan
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of APAC
The increase in healthcare awareness, along with the adoption of advanced diagnosis methods, are motivating the growth of the market in the Asia-Pacific region. Along with this, the growing population and the surge in incidence rates of chronic conditions have enhanced the need for sequencing technologies across the region. This step is likely to fuel the demand for genome mapping programs, in turn, boosting the precision medicine market on a growth path.
In the region, China is positioning itself as a global leader in precision medicine by using a patient’s genetic information to diagnose and treat various conditions. Additionally, the government is encouraging data sharing, which will open new avenues for AI companies in the healthcare sector. For instance, Shenzhen’s Beijing Genomic Institute is among the largest genetic material sequencers, helping in multiple precision diagnostics and treatments.
Furthermore, China is focusing on the treatment of heart diseases and specific cancers, including stomach cancers. Also, efforts are being taken to treat other conditions, such as metabolic and aging-related conditions. These factors indicate a robust growth of the precision medicine market in China in the next few years.
Novartis AG is a leading pharmaceutical company having a firm focus on diverse biopharmaceutical segments. It is primarily involved in R&D, manufacture, and distribution of medicines, eye products, and generic pharmaceutical products. The company’s comprehensive product portfolio includes kymriah, the first-ever CAR-T therapy approved by the FDA. It is a one-time treatment that helps to stimulate a patient’s immune system to fight against cancer. Novartis has operations across various regions, including the Asia-Pacific.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. ASIA-PACIFIC PRECISION MEDICINE MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. KEY INSIGHTS
2.1.1. PRESENCE OF BIOPHARMACEUTICAL COMPANIES
2.1.2. INVESTMENTS IN GENE THERAPY
2.2. IMPACT OF COVID-19 ON PRECISION MEDICINE MARKET
2.3. SUPPLY CHAIN OUTLOOK
2.4. ETYMOLOGY OF PRECISION MEDICINE
2.5. PORTER’S FIVE FORCES MODEL
2.6. MARKET ATTRACTIVENESS INDEX
2.7. VENDOR LANDSCAPE
2.8. KEY MARKET STRATEGIES
2.8.1. CONTRACTS AND PARTNERSHIPS
2.8.2. BUSINESS EXPANSION & DIVESTITURES
2.8.3. ACQUISITIONS & MERGERS
2.8.4. NEW PRODUCT LAUNCHES
2.9. MARKET DRIVERS
2.9.1. HIGH PREVALENCE OF CHRONIC DISEASES IN THE AGING POPULATION
2.9.2. DIGITAL COLLABORATION AMONG RESEARCH GROUPS AND ORGANIZATIONS
2.9.3. IDENTIFICATION OF GENETIC MAKEUP IN THE HUMAN GENOME
2.10. MARKET CHALLENGES
2.10.1. STRINGENT DRUG APPROVAL PROCESS
2.10.2. SECURITY THREATS PERTAINING TO DATA SHARING
2.10.3. CHANGES IN REIMBURSEMENT AND REGULATORY PROCESS
2.11. MARKET OPPORTUNITIES
2.11.1. INVESTMENTS BY GOVERNMENT AND PRIVATE PLAYERS IN CANCER TREATMENT
2.11.2. DEMAND FOR PREVENTIVE CARE
3. ASIA-PACIFIC PRECISION MEDICINE MARKET - BY APPLICATION
3.1. ONCOLOGY
3.2. INFECTIOUS DISEASES
3.3. NEUROLOGY/PHYSIATRY
3.4. CARDIOVASCULAR
3.5. LIFESTYLE AND ENDOCRINOLOGY
3.6. GASTROENTEROLOGY
3.7. OTHER APPLICATIONS
4. ASIA-PACIFIC PRECISION MEDICINE INDUSTRY - BY COMPONENT
4.1. APPLIED SCIENCE
4.1.1. GENOMICS
4.1.1.1. PCR
4.1.1.2. PM NGS
4.1.1.3. GENOME EDITING
4.1.1.4. OTHER GENOMICS TECHNOLOGIES
4.1.2. PHARMACOGENOMICS
4.1.3. OTHER APPLIED SCIENCES
4.2. PRECISION THERAPEUTICS
4.2.1. CLINICAL TRIALS
4.2.2. CELL THERAPY
4.2.3. DRUG DISCOVERY AND RESEARCH
4.2.4. GENE THERAPY
4.3. PRECISION DIAGNOSTICS
4.3.1. MOLECULAR DIAGNOSTICS
4.3.1.1. NON-INVASIVE PRENATAL TESTING (NIPT)
4.3.1.2. COMPANION DIAGNOSTICS
4.3.1.3. LIQUID BIOPSY
4.3.1.4. OTHER MOLECULAR DIAGNOSTICS
4.3.2. MEDICAL IMAGING
4.3.2.1. IMAGING ANALYTICS
4.3.2.2. IMAGING COMPUTER-AIDED DETECTION (CADX)
4.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY
4.4.1. CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
4.4.2. BIG DATA ANALYTICS
4.4.3. IT INFRASTRUCTURE
4.4.4. GENOMICS INFORMATICS
4.4.5. IN-SILICO INFORMATICS
4.4.6. MOBILE HEALTH
5. ASIA-PACIFIC PRECISION MEDICINE MARKET – REGIONAL OUTLOOK
5.1. COUNTRY ANALYSIS
5.1.1. CHINA
5.1.2. JAPAN
5.1.3. AUSTRALIA & NEW ZEALAND
5.1.4. INDIA
5.1.5. SOUTH KOREA
5.1.6. ASEAN COUNTRIES
5.1.7. REST OF ASIA-PACIFIC
6. COMPETITIVE LANDSCAPE
6.1. ABBOTT LABORATORIES
6.2. ASTRAZENECA PLC
6.3. BIOCRATES LIFE SCIENCES AG
6.4. BIO-RAD LABORATORIES INC
6.5. DANAHER CORPORATION
6.6. EAGLE GENOMICS LTD
6.7. ELI LILLY & COMPANY
6.8. F HOFFMANN-LA ROCHE AG
6.9. INTOMICS
6.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
6.11. NANOSTRING TECHNOLOGIES
6.12. NOVARTIS AG
6.13. PFIZER INC
6.14. QIAGEN NV
6.15. QUEST DIAGNOSTICS INCORPORATED
7. RESEARCH METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.1.1.  OBJECTIVES OF STUDY
7.1.2.  SCOPE OF STUDY
7.2. SOURCES OF DATA
7.2.1.  PRIMARY DATA SOURCES
7.2.2.  SECONDARY DATA SOURCES
7.3. RESEARCH METHODOLOGY
7.3.1.  EVALUATION OF PROPOSED MARKET
7.3.2.  IDENTIFICATION OF DATA SOURCES
7.3.3.  ASSESSMENT OF MARKET DETERMINANTS
7.3.4.  DATA COLLECTION
7.3.5.  DATA VALIDATION & ANALYSIS
TABLE 1:Â Â Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2:Â Â Â Â Â Â MARKET ATTRACTIVENESS INDEX
TABLE 3:Â Â Â Â Â Â VENDOR LANDSCAPE
TABLE 4:Â Â Â Â Â Â LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5:Â Â Â Â Â Â LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE 6:Â Â Â Â Â Â LIST OF ACQUISITIONS & MERGERS
TABLE 7:Â Â Â Â Â Â LIST OF NEW PRODUCT LAUNCHES
TABLE 8:Â Â Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9:Â Â Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 10:Â Â Â Â ASIA-PACIFIC APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11:Â Â Â Â ASIA-PACIFIC GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 12:Â Â Â Â ASIA-PACIFIC PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 13:Â Â Â Â ASIA-PACIFIC PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 14:Â Â Â Â ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 15:Â Â Â Â ASIA-PACIFIC MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 16:Â Â Â Â ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 17:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 2:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY APPLICATION, 2020 & 2028
FIGURE 3:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY INFECTIOUS DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 5:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY NEUROLOGY/PHYSIATRY, 2021-2028 (IN $ MILLION)
FIGURE 6:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 7:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY LIFESTYLE AND ENDOCRINOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 8:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY GASTROENTEROLOGY, 2021-2028 (IN $ MILLION)
FIGURE 9:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 10:Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COMPONENT, 2020 & 2028
FIGURE 11:Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY APPLIED SCIENCE, 2021-2028 (IN $ MILLION)
FIGURE 12:Â ASIA-PACIFIC APPLIED SCIENCE MARKET, BY GENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 13:Â ASIA-PACIFIC GENOMICS MARKET, BY PCR, 2021-2028 (IN $ MILLION)
FIGURE 14:Â ASIA-PACIFIC GENOMICS MARKET, BY PM NGS, 2021-2028 (IN $ MILLION)
FIGURE 15:Â ASIA-PACIFIC GENOMICS MARKET, GENOME EDITING, 2021-2028 (IN $ MILLION)
FIGURE 16:Â ASIA-PACIFIC GENOMICS MARKET, OTHER GENOMICS TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 17:Â ASIA-PACIFIC APPLIED SCIENCE MARKET, BY PHARMACOGENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 18:Â BIOMARKERS ROLE IN PHARMACOGENOMICS
FIGURE 19:Â ASIA-PACIFIC APPLIED SCIENCE MARKET, OTHER APPLIED SCIENCES, 2021-2028 (IN $ MILLION)
FIGURE 20:Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY PRECISION THERAPEUTICS, 2021-2028 (IN $ MILLION)
FIGURE 21:Â ASIA-PACIFIC PRECISION THERAPEUTICS MARKET, BY CLINICAL TRIALS, 2021-2028 (IN $ MILLION)
FIGURE 22:Â ASIA-PACIFIC PRECISION THERAPEUTICS MARKET, BY CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 23:Â ASIA-PACIFIC PRECISION THERAPEUTICS MARKET, BY DRUG DISCOVERY AND RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 24:Â ASIA-PACIFIC PRECISION THERAPEUTICS MARKET, BY GENE THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 25:Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY PRECISION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 26:Â ASIA-PACIFIC PRECISION DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 27:Â ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY NON-INVASIVE PRENATAL TESTING (NIPT), 2021-2028 (IN $ MILLION)
FIGURE 28:Â ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 29:Â ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY LIQUID BIOPSY, 2021-2028 (IN $ MILLION)
FIGURE 30:Â ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY OTHER MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 31:Â ASIA-PACIFIC PRECISION DIAGNOSTICS MARKET, BY MEDICAL IMAGING, 2021-2028 (IN $ MILLION)
FIGURE 32:Â ASIA-PACIFIC MEDICAL IMAGING MARKET, BY IMAGING ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 33:Â ASIA-PACIFIC MEDICAL IMAGING MARKET, BY IMAGING COMPUTER-AIDED DETECTION (CADX), 2021-2028 (IN $ MILLION)
FIGURE 34:Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY DIGITAL HEALTH AND INFORMATION TECHNOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 35:Â ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY CLINICAL DECISION SUPPORT SYSTEMS (CDSS), 2021-2028 (IN $ MILLION)
FIGURE 36:Â ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY BIG DATA ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 37:Â ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IT INFRASTRUCTURE, 2021-2028 (IN $ MILLION)
FIGURE 38:Â ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY GENOMICS INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 39:Â ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IN-SILICO INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 40:Â ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY MOBILE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 41:Â CHINA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 42:Â JAPAN PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 43:Â AUSTRALIA & NEW ZEALAND PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 44:Â INDIA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 45:Â SOUTH KOREA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 46:Â ASEAN COUNTRIES PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 47:Â REST OF ASIA-PACIFIC PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)